Two fast track designations for Corey Goodman's new startup; Vifor/Akebia secure priority review voucher
→ Corey Goodman‘s CD47 startup ALX Oncology has cinched two fast track designations from the FDA for its lead candidate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
